Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 4 [44-168]
Ligand
BDBM205452
Substrate
n/a
Meas. Tech.
AlphaScreen BRD Binding Assay
pH
7.5±n/a
Temperature
298.15±n/a K
IC50
30.5±0.0 nM
Comments
extracted
Citation
 Tanaka, M; Roberts, JM; Seo, HS; Souza, A; Paulk, J; Scott, TG; DeAngelo, SL; Dhe-Paganon, S; Bradner, JE Design and characterization of bivalent BET inhibitors. Nat Chem Biol 12:1089-1096 (2016) [PubMed]  Article 
Target
Name:
Bromodomain-containing protein 4 [44-168]
Synonyms:
BET bromodomain 4(1) (BRD4(1)) | BRD4 | BRD4-BD1 protein (aa 44-168) | BRD4_HUMAN | Bromodomain protein 4 (BRD4-BD1) | Bromodomain-containing protein 4 (BRD4-BD1) | Bromodomain-containing protein 4 (BRD4) (aa 44-168) | Bromodomain-containing protein 4 (BRD4-BD1) | Bromodomain-containing protein 4 bromodomain 1 (BRD4-BD1) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14866.49
Organism:
Homo sapiens (Human)
Description:
aa (44-168)
Residue:
125
Sequence:
NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE
  
Inhibitor
Name:
BDBM205452
Synonyms:
IBETx2-PEG7 (34)
Type:
Small organic molecule
Emp. Form.:
C66H78N12O15
Mol. Mass.:
1279.3969
SMILES:
COc1cc2c3n([C@@H](C)c4ccccn4)c(=O)n(CC(=O)NCCOCCOCCOCCOCCOCCOCCOCCNC(=O)Cn4c5cnc6cc(-c7c(C)noc7C)c(OC)cc6c5n([C@H](C)c5ccccn5)c4=O)c3cnc2cc1-c1c(C)noc1C |r,wD:70.74,7.7,(-6.8,-1.11,;-5.46,-.34,;-4.13,.43,;-2.8,-.34,;-1.46,.43,;-.13,-.34,;.35,-1.8,;-.66,-2.74,;-2.2,-2.35,;-.22,-3.91,;1.32,-3.91,;2.09,-5.24,;1.32,-6.58,;-.22,-6.58,;-.99,-5.24,;1.89,-1.8,;2.66,-3.14,;2.36,-.34,;3.7,.43,;5.45,-.22,;5.94,-1.68,;6.84,1.15,;8.15,.06,;9.26,.83,;10.6,.06,;11.93,.83,;13.26,.06,;14.6,.83,;15.69,-.26,;17.02,.51,;18.11,-.58,;19.77,.19,;20.78,-.58,;22.33,.52,;23.97,-.57,;24.75,.2,;26.09,-.57,;27.42,.2,;28.75,-.57,;30.09,.2,;31.42,-.57,;32.76,.2,;34.09,-.57,;35.42,.2,;36.76,-.57,;38.31,.33,;39.75,-.44,;39.64,-2.53,;40.84,.65,;42.17,-.12,;43.33,.65,;43.33,2.19,;44.66,2.96,;46,2.19,;47.33,2.96,;48.67,2.19,;50,2.96,;51.33,2.19,;51.33,.65,;52.42,3.28,;51.72,4.65,;50.2,4.41,;49.11,5.5,;48.67,.65,;50,-.12,;51.33,-.89,;47.33,-.12,;46,.65,;44.66,-.12,;44.19,-1.59,;45.19,-2.52,;46.73,-2.14,;44.75,-3.69,;43.21,-3.69,;42.44,-5.03,;43.21,-6.36,;44.75,-6.36,;45.52,-5.03,;42.65,-1.59,;41.88,-2.92,;1.2,.43,;1.2,1.97,;-.13,2.74,;-1.46,1.97,;-2.8,2.74,;-4.13,1.97,;-5.46,2.74,;-6.8,1.97,;-6.8,.43,;-7.89,3.06,;-7.19,4.43,;-5.67,4.19,;-4.58,5.28,)|
Structure:
Search PDB for entries with ligand similarity: